Drugmaker Viatris to buy pain medicine creator Pacira BioSciences
MLex Summary: Pharmaceutical company Viatris has agreed to pay $1.65 billion for Pacira BioSciences, which sells non-opioid pain medicines within the US, according to a release. "Viatris plans to leverage its...To view the full article, register now.
Already a subscriber? Click here to view full article